Themis Medicare

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083B01024
  • NSEID: THEMISMED
  • BSEID: 530199
INR
101.60
-1.85 (-1.79%)
BSENSE

Jun 18

BSE+NSE Vol: 43.78 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 469937,
    "name": "Themis Medicare",
    "stock_name": "Themis Medicare",
    "full_name": "Themis Medicare Ltd",
    "name_url": "stocks-analysis/themis-medicare",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "101.60",
    "chg": -1.85,
    "chgp": "-1.79%",
    "dir": -1,
    "prev_price": "103.45",
    "mcapval": "935.74 Cr",
    "mcap": "Small Cap",
    "scripcode": 530199,
    "symbol": "THEMISMED",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE083B01024",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "43.78 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/themis-medicare-469937-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Themis Medicare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-is-rated-sell-4002668",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThemisMedicareL_mojoScore_4002668.png",
        "date": "2026-05-21 10:10:58",
        "description": "Themis Medicare Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 21 May 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Themis Medicare Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-is-rated-sell-by-marketsmojo-3983927",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ThemisMedicareL_mojoScore_3983927.png",
        "date": "2026-05-10 10:10:37",
        "description": "Themis Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Themis Medicare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-is-rated-sell-3967986",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ThemisMedicareL_mojoScore_3967986.png",
        "date": "2026-04-29 10:10:53",
        "description": "Themis Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Themis Medicare Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-is-rated-sell-3951877",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ThemisMedicareL_mojoScore_3951877.png",
        "date": "2026-04-18 10:10:38",
        "description": "Themis Medicare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 April 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Themis Medicare Gains 3.87%: Technical Shifts Amid Persistent Fundamental Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicare-gains-387-technical-shifts-amid-persistent-fundamental-challenges-3943101",
        "imagepath": "",
        "date": "2026-04-11 17:06:40",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>6 Apr:</strong> Week opens at Rs.80.45</p>\n                    <p><strong>7 Apr:</strong> Mojo Grade upgraded to Sell from Strong Sell</p>\n                    <p><strong>8 Apr:</strong> Stock surges 4.01% amid positive technical momentum</p>\n                    <p><strong>10 Apr:</strong> Week closes at Rs.83.56, up 3.87% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.80.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.83.56</div><div class=\"stat-change positive\">+3..."
      },
      {
        "title": "Themis Medicare Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/themis-medicare-ltd-is-rated-strong-sell-3923738",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ThemisMedicareL_mojoScore_3923738.png",
        "date": "2026-03-30 10:10:31",
        "description": "Themis Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Themis Medicare Ltd Falls to 52-Week Low of Rs 70.52 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/themis-medicare-ltd-stock-hits-52-week-low-at-rs7052-amidst-continued-downtrend-3910839",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ThemisMedicareL_priceRelatedfactors_3910839.png",
        "date": "2026-03-24 15:17:05",
        "description": "A sharp decline of over 60% from its 52-week high has dragged Themis Medicare Ltd to a fresh 52-week low of Rs 70.52 on 24 Mar 2026, underscoring persistent selling pressure amid deteriorating fundamentals and subdued market sentiment."
      }
    ],
    "total": 15,
    "sid": "469937",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/themis-medicare-469937"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "29-May-2026",
      "details": "Annual Secretarial Compliance Report for the financial year ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-May-2026",
      "details": "Newspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31.03.2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Dated 28Th May 2026",
      "datetime": "28-May-2026",
      "details": "1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2026 together with the Report issued by the Statutory Auditors M/s. Krishaan & Co. Chartered Accountants which are attached herewith. 2. Recommended final dividend of Re. 0.50 i.e. @ 50 % per equity share having face value of Re.1/- each aggregating to Rs. 46050060 /- for the Financial Year ended 31st March 2026 subject to the approval of shareholders at the forthcoming Annual General Meeting. 3. Appointment of M/s. R. Nanabhoy & Co. Cost Accountants (FRN - 000011) as the Cost Auditor of the Company for the Financial Year Financial Year 2026-27.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Themis Medicare Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 25",
          "dt": "2025-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Themis Medicare Ltd has announced <strong>1:10</strong> stock split, ex-date: 10 Oct 23",
          "dt": "2023-10-10",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Compliances-Reg.24(A)-Annual Secretarial Compliance

29-May-2026 | Source : BSE

Annual Secretarial Compliance Report for the financial year ended 31st March 2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

29-May-2026 | Source : BSE

Newspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31.03.2026

Board Meeting Outcome for Outcome Of The Board Meeting Dated 28Th May 2026

28-May-2026 | Source : BSE

1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2026 together with the Report issued by the Statutory Auditors M/s. Krishaan & Co. Chartered Accountants which are attached herewith. 2. Recommended final dividend of Re. 0.50 i.e. @ 50 % per equity share having face value of Re.1/- each aggregating to Rs. 46050060 /- for the Financial Year ended 31st March 2026 subject to the approval of shareholders at the forthcoming Annual General Meeting. 3. Appointment of M/s. R. Nanabhoy & Co. Cost Accountants (FRN - 000011) as the Cost Auditor of the Company for the Financial Year Financial Year 2026-27.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Themis Medicare Ltd has declared 50% dividend, ex-date: 04 Sep 25

stock-summary
SPLITS

Themis Medicare Ltd has announced 1:10 stock split, ex-date: 10 Oct 23

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available